Ποια είναι η τιμή για Polydex Pharmaceuticals Limited (POLXF)

Η τιμή για Polydex Pharmaceuticals Limited (POLXF) είναι $1.99

Ποια είναι η κεφαλαιοποίηση αγοράς για Polydex Pharmaceuticals Limited (POLXF)

Η κεφαλαιοποίηση αγοράς για Polydex Pharmaceuticals Limited (POLXF) είναι $6.82M

Polydex Pharmaceuticals Limited (POLXF) Τιμή και Κεφαλαιοποίηση Αγοράς

Polydex Pharmaceuticals Limited (PPL), a Toronto, Canada-based company, was incorporated in 1979 and initially operated as Polydex Chemicals Limited before adopting its current name in March 1984. PPL specializes in the research, development, manufacturing, and global marketing of biotechnology-derived products for the human pharmaceutical sector. Beyond its human health focus, PPL also produces vital pharmaceutical intermediates for the veterinary industry. Its core product line centers on dextran and its various derivatives. Notable examples include iron dextran, a compound administered to newborn pigs to combat anemia, and dextran sulphate, a specialized chemical derivative crucial for biotechnology applications and the broader pharmaceutical sector. Furthermore, the company is actively developing Ushercell, a high molecular weight cellulose sulphate. This innovative product is designed for topical vaginal use, primarily aimed at preventing the transmission of AIDS and other sexually transmitted diseases, as well as unplanned pregnancies. PPL's portfolio further extends to supplying ferric hydroxide and hydrogenated dextran solutions. Products reach the market through a combination of independent distributors, wholesalers, and direct sales channels to various companies.

Η τιμή για POLXF	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$1,588,258 $6.82M	NVDA	$5.452T	+79,972,615.54%
$1,308,049 $6.82M	AAPL	$4.490T	+65,863,402.81%
$1,212,608 $6.82M	GOOG	$4.162T	+61,057,689.50%
$1,071,006 $6.82M	MSFT	$3.676T	+53,927,673.47%
$825,332 $6.82M	AMZN	$2.833T	+41,557,421.77%

Η τιμή για POLXF

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$1,588,258 $6.82M